Magenta Therapeutics (MGTA) PT Lowered to $19 at B.Riley
Get Alerts MGTA Hot Sheet
Price: $0.70 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
B.Riley analyst Kalpit Patel lowered the price target on Magenta Therapeutics (NASDAQ: MGTA) to $19.00 (from $21.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- SM Prime Holdings, Inc (SMPH:PM) (SPHXF) PT Lowered to PHP21 at JPMorgan
- JD Logistics Inc (2618:HK) (JDLGF) PT Lowered to HK$18 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share